Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Zura Bio Ltd as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +17 vs. Q2 2021
- Shares held
- 3.21M
- +3.21M vs. Q2 2021
- Total value
- $31.6M
- +$31.6M vs. Q2 2021
- New holders
- 17
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $428.9M |
| Q1 2026 | 94 | $391.8M |
| Q4 2025 | 75 | $235.1M |
| Q3 2025 | 69 | $179.2M |
| Q2 2025 | 65 | $37.1M |
| Q1 2025 | 74 | $59.0M |
| Q4 2024 | 87 | $107.2M |
| Q3 2024 | 78 | $151.1M |
| Q2 2024 | 57 | $114.9M |
| Q1 2024 | 45 | $37.6M |
| Q4 2023 | 44 | $70.7M |
| Q3 2023 | 41 | $93.3M |
| Q2 2023 | 38 | $105.0M |
| Q1 2023 | 3 | $24.7K |
| Q4 2022 | 35 | $87.4M |
| Q3 2022 | 33 | $84.2M |
| Q2 2022 | 36 | $77.7M |
| Q1 2022 | 34 | $58.1M |
| Q4 2021 | 25 | $48.5M |
| Q3 2021 | 17 | $31.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Zura Bio Ltd; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 1,188,000 | $11.7M | 0.16% | +1,188,000 | New |
| Boussard & Gavaudan Investment Management LLP | 375,000 | $3.68M | 0.34% | +375,000 | New |
| Spring Creek Capital LLC | 300,000 | $2.95M | 0.15% | +300,000 | New |
| UBS Oconnor LLC | 250,979 | $2.47M | 0.02% | +250,979 | New |
| Radcliffe Capital Management, L.P. | 250,000 | $2.46M | 0.10% | +250,000 | New |
| Polar Asset Management Partners Inc. | 200,000 | $1.97M | 0.02% | +200,000 | New |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 150,000 | $1.47M | 0.02% | +150,000 | New |
| Berkley W R Corp | 121,016 | $1.18M | 0.08% | +121,016 | New |
| Gabelli Funds LLC | 108,600 | $1.06M | 0.01% | +108,600 | New |
| Gabelli & Co Investment Advisers, Inc. | 91,400 | $894.0K | 0.11% | +91,400 | New |
| Glazer Capital, LLC | 65,708 | $642.0K | 0.01% | +65,708 | New |
| Highland Capital Management Fund Advisors, L.P. | 31,000 | $306.0K | 0.05% | +31,000 | New |
| Basso Capital Management, L.P. | 25,000 | $247.0K | 0.03% | +25,000 | New |
| CVI Holdings, LLC | 24,600 | $241.0K | 0.02% | +24,600 | New |
| Schonfeld Strategic Advisors LLC | 20,000 | $197.0K | 0.00% | +20,000 | New |
| Warberg Asset Management LLC | 10,000 | $99.0K | 0.03% | +10,000 | New |
| Wolverine Asset Management LLC | 105 | $1.00K | 0.00% | +105 | New |